Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer

被引：0
|
作者：
Taroh Satoh
Yasushi Omuro
Yasutsuna Sasaki
Yasuo Hamamoto
Narikazu Boku
Takao Tamura
Atsushi Ohtsu
机构：
[1] Osaka University,Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine
[2] Komagome Hospital,Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center
[3] Saitama Medical University,Department of Medical Oncology, Saitama International Medical Center–Comprehensive Cancer Center
[4] Tochigi Cancer Center,Department of Medical Oncology
[5] Shizuoka Cancer Center,Department of Gastrointestinal Oncology
[6] Kinki University Faculty of Medicine,Department of Medical Oncology, Nara Hospital
[7] National Cancer Center Hospital East,Research Center for Innovative Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Capecitabine; Cisplatin; Trastuzumab; ToGA study; Pharmacokinetics; Advanced gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：949 / 955
页数：6
相关论文
共 50 条
  • [1] Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer
    Satoh, Taroh
    Omuro, Yasushi
    Sasaki, Yasutsuna
    Hamamoto, Yasuo
    Boku, Narikazu
    Tamura, Takao
    Ohtsu, Atsushi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 949 - 955
  • [2] A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients
    Zhu, Bo
    Wu, Jun-Rong
    Zhou, Xiao-Ping
    MEDICINE, 2015, 94 (34) : e1428
  • [3] The use of trastuzumab in Japanese patients with HER2-positive advanced or metastatic gastric cancer
    Sawaki, A.
    Ohashi, Y.
    Omuro, Y.
    Satoh, T.
    Hamamoto, Y.
    Boku, N.
    Miyata, Y.
    Takiuchi, H.
    Ohtsu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [4] Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis
    Okita, Akira
    Imai, Hiroo
    Takahashi, Masahiro
    Takahashi, Hidekazu
    Umegaki, Sho
    Kawamura, Yoshifumi
    Hiraide, Sakura
    Ouchi, Kota
    Sato, Yuko
    Okada, Yoshinari
    Komine, Keigo
    Saijo, Ken
    Takahashi, Shin
    Takahashi, Masanobu
    Shirota, Hidekazu
    Ohori, Hisatsugu
    Gamoh, Makio
    Ishioka, Chikashi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 245 (02): : 123 - 129
  • [5] Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
    Akira Sawaki
    Yasuo Ohashi
    Yasushi Omuro
    Taroh Satoh
    Yasuo Hamamoto
    Narikazu Boku
    Yoshinori Miyata
    Hiroya Takiuchi
    Kensei Yamaguchi
    Yasutsuna Sasaki
    Tomohiro Nishina
    Atsushi Satoh
    Eishi Baba
    Takao Tamura
    Takashi Abe
    Kiyohiko Hatake
    Atsushi Ohtsu
    Gastric Cancer, 2012, 15 : 313 - 322
  • [6] Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
    Sawaki, Akira
    Ohashi, Yasuo
    Omuro, Yasushi
    Satoh, Taroh
    Hamamoto, Yasuo
    Boku, Narikazu
    Miyata, Yoshinori
    Takiuchi, Hiroya
    Yamaguchi, Kensei
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Satoh, Atsushi
    Baba, Eishi
    Tamura, Takao
    Abe, Takashi
    Hatake, Kiyohiko
    Ohtsu, Atsushi
    GASTRIC CANCER, 2012, 15 (03) : 313 - 322
  • [7] A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
    Y-K Kang
    S Y Rha
    P Tassone
    J Barriuso
    R Yu
    T Szado
    A Garg
    Y-J Bang
    British Journal of Cancer, 2014, 111 : 660 - 666
  • [8] A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
    Kang, Y-K
    Rha, S. Y.
    Tassone, P.
    Barriuso, J.
    Yu, R.
    Szado, T.
    Garg, A.
    Bang, Y-J
    BRITISH JOURNAL OF CANCER, 2014, 111 (04) : 660 - 666
  • [9] Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
    Park, Ji Soo
    Youn, Jong-Chan
    Shim, Chi Young
    Hong, Geu-Ru
    Lee, Choong-Kun
    Kim, Jee Hyung
    Park, Hyung Soon
    Heo, Su Jin
    Beom, Seung Hoon
    Kim, Hyo Song
    Rha, Sun Young
    Chung, Hyun Cheol
    Kang, Seok-Min
    Jung, Minkyu
    ONCOTARGET, 2017, 8 (37) : 61837 - 61845
  • [10] Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer
    Watanabe, Junichiro
    Ito, Yoshinori
    Saeki, Toshiaki
    Masuda, Norikazu
    Takano, Toshimi
    Takao, Shintaro
    Nakagami, Kazuhiko
    Tsugawa, Koichiro
    Nakagawa, Shintaro
    Kanatani, Kazumitsu
    Nakayama, Takahiro
    IN VIVO, 2017, 31 (03): : 493 - 500
12345